Menu
Itraconazole

Itraconazole Pellets 22%

Itraconazole (R51211), invented in 1984, is a triazole antifungal agent prescribed to patients with fungal infections. The drug may be given orally or intravenously.

 Make an enquiry for this product

Starting at

Compare

Product Description


(2R,4S)-rel-1-(Butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydr

Trade names Sporanox
AHFS/Drugs.com monograph
MedlinePlus a692049
Pregnancy
category
AU: B3
US: C (Risk not ruled out)
Legal status AU: S4 (Prescription only)
CA: ℞-only
UK: POM (Prescription only)
US: ℞-only
Routes of
administration
Oral and i.v. ,Oral only (UK and US)

Bioavailability 55%, maximal if taken with full meal
Protein binding 99.8%
Metabolism hepatic (CYP3A4)
Biological half-life 21 hours
Excretion Urine, faeces

CAS Number 84625-61-6
ATC code J02AC02
PubChem CID: 55283
DrugBank DB01167
ChemSpider 49927
UNII 304NUG5GF4
KEGG D00350
ChEBI CHEBI:6076
ChEMBL CHEMBL22587

Formula C35H38Cl2N8O4
Molecular mass 705.64
SMILES[show]
InChI[show]